PharmaBoardroom

From Hype to Health: Delivering on the Promise of AI in Biopharma

Krishna Cheriath, chief data officer at BMS, outlines the ways in which AI is already transforming the delivery of healthcare, what modern biopharma…

China’s CARsgen Therapeutics Wins US FDA Orphan Drug…

The US FDA has granted orphan drug designation to Shanghai-headquartered biotech CARsgen Therapeutics' CAR-T cell therapy CT053 for multiple myeloma…

How AI is Transforming Pharmacovigilance

Bayer’s Michael Levy examines how artificial intelligence (AI) can assist in both the routine and advanced analytical tasks involved in conducting…

5 More Biotechs to Watch in China

Earlier this year, PharmaBoardroom highlighted five of the most innovative and important biotech companies making waves in the world’s…

Leo Liu – President, GeneReach, Taiwan

Leo Liu, president of GeneReach Biotechnology Corp, shares the story of the diagnostics startup and explains his strategy to transition the company…

Shing-Mou Lee – Founder and President, EMO Biomedicine,…

Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory…

HB Chen – President, TaiwanBio Therapeutics

HB Chen, president of TaiwanBio Therapeutics, introduces the innovative stem cell company and elaborates on their patented cell expansion technique…

Cell & Gene Therapies: Transforming our Vision of Healthcare…

Emanuele Ostuni, head of cell & gene therapy for Novartis Oncology in Europe, outlines how stakeholders across the biopharmaceutical value chain…

Bayer: Betting Big on Cell & Gene Therapy

Bayer's latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as the company increasingly looks toward cell…

Christian Vallentin – Country Manager, Orifarm Sweden

Orifarm is the largest supplier of parallel imported medicines in the EU and a fast-growing supplier of generic pharmaceuticals in the Nordic…

US Medicare Vows to Increase Payments for Cell & Gene…

Medicare, a national health insurance program in the United States covering Americans aged 65 and older as well as younger people with disabilities,…

How US Healthcare Can Better Accommodate Cell & Gene…

PhRMA's Anne McDonald Pritchett PhD highlights the remarkable development of cell and gene therapies in recent years and the three ways in which the…

Tagged with GEN